• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Humana Expands Science-Based Targets with New SBTi-Validated Target

    6/24/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email

    New target aims to reduce emissions from investments and lending activities, aligning financial influence with operational impact

    Humana Inc. (NYSE:HUM), one of the nation's leading health and well-being companies, today announced the expansion of its validated science-based target (SBT) with recent approval of a new financial institution target by the Science Based Targets initiative (SBTi). This milestone highlights Humana's dedication to sustainability, reinforcing its commitment to improving health and well-being while aiming for significant emissions reductions across the company's value chain.

    The following outlines Humana's Scope 3 asset class level target, emphasizing our commitment to sustainable investment practices and alignment with SBTi-validated goals.

    Scope 3 asset class level target

    Asset class

    Method

    Target language

    Listed equity and

    corporate bonds

    Portfolio Coverage

    Humana Inc. commits to 67.3% of its listed equity and corporate bond portfolio by invested value setting SBTi-validated targets by 2029 from a 2022 base year.

    This complements the company's existing targets covering the rest of its value chain, including a commitment to reduce absolute Scope 3 emissions from purchased goods and services, as well as upstream transportation and distribution, by 30% by 2032 from a 2022 base year. The newly approved target for Scope 3, Category 15 financed emissions refer to the indirect greenhouse gas emissions from investments and lending activities.

    To achieve the financed emissions target, Humana has revised its investment policy to incorporate SBTi-aligned climate commitments. These proactive measures highlight Humana's commitment to fostering healthier environments for its members, patients, employees, and communities, and aligns its financial influence with its operational impact.

    Humana's Scope 1 and 2 targets, approved in 2023, remain unchanged and continue to align with limiting global temperature rise. The company's science-based targets and 1.5°C trajectory are designed to spur innovation and efficiency demonstrating ongoing leadership in climate action within the healthcare and insurance sectors, boost investor confidence and position Humana to support a broader decarbonization effort across its value chain and financial ecosystem.

    To learn more about Humana's environmental, social and governance strategy efforts to invest in the health and sustainability of our environment, visit the Humana Impact Report.

    About Science Based Targets initiative

    The Science Based Targets initiative (SBTi) is a collaboration between Carbon Disclosure Project (CDP), the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF).

    The SBTi defines and promotes best practice in science-based target setting and independently assesses companies' targets.

    About Humana

    Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250624933843/en/

    FOR MORE INFORMATION, CONTACT:

    Sara Nelson

    Humana Corporate Communications

    [email protected]

    Get the next $HUM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    10/8/2024$308.00Mkt Perform → Outperform
    Bernstein
    10/7/2024$402.00 → $261.00Buy → Hold
    TD Cowen
    10/7/2024$519.00 → $253.00Buy → Hold
    Jefferies
    10/3/2024$392.00 → $274.00Overweight → Neutral
    Piper Sandler
    10/2/2024$376.00 → $247.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

      4 - HUMANA INC (0000049071) (Issuer)

      5/16/25 4:48:13 PM ET
      $HUM
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Smith Gordon

      4 - HUMANA INC (0000049071) (Issuer)

      4/2/25 1:46:09 PM ET
      $HUM
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Hilzinger Kurt J

      4 - HUMANA INC (0000049071) (Issuer)

      4/2/25 1:45:12 PM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Humana Expands Science-Based Targets with New SBTi-Validated Target

      New target aims to reduce emissions from investments and lending activities, aligning financial influence with operational impact Humana Inc. (NYSE:HUM), one of the nation's leading health and well-being companies, today announced the expansion of its validated science-based target (SBT) with recent approval of a new financial institution target by the Science Based Targets initiative (SBTi). This milestone highlights Humana's dedication to sustainability, reinforcing its commitment to improving health and well-being while aiming for significant emissions reductions across the company's value chain. The following outlines Humana's Scope 3 asset class level target, emphasizing our commit

      6/24/25 9:00:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • For Americans, Every Day Is Independence Day When It Comes to Their Health

      New survey reveals that Americans prioritize independence and self-sufficiency as they age Nearly half feel that the U.S. views aging in a negative light Americans are signaling a shift in what it means to live a fulfilling life, with many preferring independence over longevity without self-sufficiency. While seniors, in particular, maintain an optimistic outlook on aging, they face significant challenges as they grow older, including financial strain, anxiety about future mental health and persistent negative cultural attitudes toward aging. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623607270/en/ These are among the

      6/23/25 9:00:00 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

      Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

      6/18/25 8:30:00 AM ET
      $HUM
      Medical Specialities
      Health Care

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Humana upgraded by Raymond James with a new price target

      Raymond James upgraded Humana from Mkt Perform to Outperform and set a new price target of $315.00

      5/1/25 7:42:13 AM ET
      $HUM
      Medical Specialities
      Health Care
    • Humana upgraded by BofA Securities with a new price target

      BofA Securities upgraded Humana from Underperform to Neutral and set a new price target of $308.00 from $247.00 previously

      11/6/24 8:21:46 AM ET
      $HUM
      Medical Specialities
      Health Care
    • KeyBanc Capital Markets initiated coverage on Humana

      KeyBanc Capital Markets initiated coverage of Humana with a rating of Sector Weight

      10/11/24 7:47:34 AM ET
      $HUM
      Medical Specialities
      Health Care